Advanced Rehabilitation Technology for Neurological Disorders
Trial Summary
What is the purpose of this trial?
A pre-post, randomized control trial comparing cost-effective and functional outcomes of participants with neurological diagnoses using robotic devices and advanced technology during inpatient rehabilitation to the outcomes of control participants without the use of robotic devices and advanced technology during rehabilitation. We aim to show at least similar inpatient rehabilitation outcomes and improved health economics in participants with neurological diagnoses by using robotic devices and advanced technology to increase the intensity and dose of rehabilitation.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators or your doctor for guidance.
What data supports the idea that Advanced Rehabilitation Technology for Neurological Disorders is an effective treatment?
The available research shows that Advanced Rehabilitation Technology, like the Ekso Bionics exoskeleton, is effective in improving mobility and user satisfaction for people with neurological disorders. Patients reported improved mobility and high satisfaction after using the Ekso device during rehabilitation. In a study with people with multiple sclerosis, both patients and physiotherapists expressed high satisfaction with the treatment, highlighting its effectiveness and safety. Additionally, therapists found the technology useful for saving time and effort, which increased their willingness to use it. While there are some challenges in integrating these technologies into clinical practice, the overall feedback from users and therapists is positive, indicating that these devices can be a valuable part of rehabilitation.12345
What safety data is available for advanced rehabilitation technology for neurological disorders?
The safety data for advanced rehabilitation technology, including devices like Ekso Bionics and Fourier Intelligence exoskeletons, indicates that these devices are generally well-tolerated by patients without complications or adverse incidents. Studies have shown that patients using the Ekso exoskeleton reported improved mobility and satisfaction. However, a systematic review of stationary gait robots found reports of adverse events, such as soft tissue and musculoskeletal injuries, and physiological changes like blood pressure fluctuations. These risks are often due to excessive pressure, shear, and misalignments between the robot and human joints. The need for more structured reporting of adverse events is emphasized to improve safety measures in robotic-assisted rehabilitation.15678
Is the treatment in the trial 'Advanced Rehabilitation Technology for Neurological Disorders' promising?
Yes, the treatment is promising. Robotic exoskeletons like the Ekso Gait Training device can help people with neurological disorders learn to walk again. Patients reported improved mobility and felt secure using the device. The technology is becoming more accepted in rehabilitation settings, and it shows potential to improve the effectiveness of therapy.19101112
Research Team
Brett Schoen, MD
Principal Investigator
Rehabilitation Hospital of Overland Park
Eligibility Criteria
This trial is for adults over 18 with neurological disorders who are in inpatient rehab and can stay at least 7 days. They must be able to communicate, follow commands, fit into a device, and tolerate certain positions. Excluded are those with conditions limiting study benefits or involved in another study.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- EKSO Bionics
- Fourier Intelligence
- Thera-Trainer
- Tyromotion
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rehabilitation Hospital of Overland Park
Lead Sponsor
Discovery Statistics
Collaborator